Health Care & Life Sciences » Pharmaceuticals | Fuso Pharmaceutical Industries Ltd.

Fuso Pharmaceutical Industries Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
2,649
652
117
1,061
1,361
1,255
Depreciation, Depletion & Amortization
1,878
1,914
1,513
2,004
1,921
1,967
Other Funds
2,566
286
395
446
1,066
277
Funds from Operations
1,961
2,280
2,025
2,620
2,215
2,945
Changes in Working Capital
928
337
178
590
688
799
Net Operating Cash Flow
2,889
1,943
2,203
2,030
1,527
2,146
Capital Expenditures
1,655
2,538
5,312
1,838
1,717
Sale of Fixed Assets & Businesses
-
-
-
1,374
743
Purchase/Sale of Investments
100
-
32
77
50
Net Investing Cash Flow
1,779
2,890
5,421
940
1,091
Cash Dividends Paid - Total
812
722
721
717
706
Issuance/Reduction of Debt, Net
1,599
223
3,054
145
1,205
Net Financing Cash Flow
2,425
955
2,326
1,145
69
Net Change in Cash
1,315
1,902
892
55
505
Free Cash Flow
1,234
595
3,109
192
566
Other Sources
314
126
-
-
-
Change in Capital Stock
14
10
7
282
427
Other Uses
338
478
141
400
166

About Fuso Pharmaceutical Industries

View Profile
Address
2-3-11 Morinomiya
Osaka Osaka 536
Japan
Employees -
Website http://www.fuso-pharm.co.jp
Updated 07/08/2019
Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs.